Professional Certification Commission Website Banner


Print this page         


The CPIP program is closed to new candidates from Nov 30, 2013

Retaining the CPIP Designation

Once the CPIP is conferred, recertification requirements must be met every three years to maintain a valid credential. The CPIP designation becomes invalid if there is failure to meet recertification requirements.

The purpose of the CPIP Recertification Requirements Program is to:

  • Assure that the individual has maintained knowledge of current industry practices and government regulations
  • Encourage and assure continuous professional development and acquisition of knowledge and skills
  • Assure the credentialed individual has maintained the specific knowledge and skills required to operate in the pharmaceutical industry

Each CPIP must satisfy the CPIP recertification requirements in order to maintain the CPIP credential. CPIPs are required to attain no less than 60 recertification points* (RCPs) during the three year credential validity period and agree to continue to adhere to the ISPE-PCC Code of Ethics and Professional Conduct.


Documents for Download

Recertification Application Fees

Yearly Fee: US$75, €40

*See the CPIP Recertification Handbook for a description of Recertification Activities and Points.

Sam DeMarco, CPIP, President Compliance Team Inc, United States

"I believe that the credential has made me more confident and I feel that my clients engage me in more philosophical discussions on pharmaceutical industry subject matter. I get the sense that my clients 'listen' to me in a more serious 'in tune' way."

Marc Fleischman, CPIP, Facility and Verification Engineer, Genzyme, a Sanofi Company

"I chose to pursue the CPIP certification as a way to learn new phases of the industry and to codify my existing knowledge. As I prepared and studied for the exam, I was challenged to develop a broader understanding of many industry concepts that I had not been routinely exposed to. The experience has left me with a deep understanding of GMP regulation and broad industry knowledge across the entire bio/pharm lifecycle."